Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review...
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
About this item
Full title
Author / Creator
Seki, Hiroyuki , Ideno, Satoshi , Shiga, Toshiya , Watanabe, Hidenobu , Ono, Motoaki , Motoyasu, Akira , Noguchi, Hikari , Kondo, Kazuya , Yoshikawa, Takahiro , Hoshijima, Hiroshi , Hyuga, Shunsuke , Shishii, Miho , Nagai, Ai , Higashi, Midoriko , Ouchi, Takashi , Yasuda, Kazuki and Kuratani, Norifumi
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Although the recommended preoperative cessation period for sodium-glucose cotransporter 2 inhibitors (SGLT2is) changed in 2020 (from 24 h to 3–4 days preoperatively) to reduce the risk of SGLT2i-associated perioperative ketoacidosis (SAPKA), the validity of the new recommendation has not been verified. Using case reports, we assessed the new recomm...
Alternative Titles
Full title
Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10229478
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10229478
Other Identifiers
ISSN
0913-8668
E-ISSN
1438-8359
DOI
10.1007/s00540-023-03174-8
